Abstract
Myogenic stem cells are composed of satellite cells, multipotential muscle-derived stem cells and bone-marrow mesenchymal stem cells. They are multipotential stem cells that can differentiate into different cell lineages. Usually, they have the ability to commit to myogenesis, adipogenesis, and osteogenesis, which is important for the tissue growth and regeneration and even the cure of diseases. Signal proteins are major members of each signaling pathway. They transmit mass signals in or between cells and regulate gene expression, so ensure the homeostasis of the organism. Here, we review the origin, properties and applications of myogenic stem cells, and the vital signal proteins involved in myogenic stem cells differentiation will be referred to as well.
Keywords: Bone-marrow mesenchymal stem cells, differentiation, multipotential muscle-derived stem cells, satellite cells, signal proteins.
Graphical Abstract
Current Protein & Peptide Science
Title:Signal Proteins Involved in Myogenic Stem Cells Differentiation
Volume: 18 Issue: 6
Author(s): Zhiqing Huang, Xiaoyan Wang and Daiwen Chen*
Affiliation:
- Key Laboratory for Animal Disease-Resistance Nutrition of China Ministry of Education, Institute of Animal Nutrition, Sichuan Agricultural University, Chengdu, Sichuan 611130,China
Keywords: Bone-marrow mesenchymal stem cells, differentiation, multipotential muscle-derived stem cells, satellite cells, signal proteins.
Abstract: Myogenic stem cells are composed of satellite cells, multipotential muscle-derived stem cells and bone-marrow mesenchymal stem cells. They are multipotential stem cells that can differentiate into different cell lineages. Usually, they have the ability to commit to myogenesis, adipogenesis, and osteogenesis, which is important for the tissue growth and regeneration and even the cure of diseases. Signal proteins are major members of each signaling pathway. They transmit mass signals in or between cells and regulate gene expression, so ensure the homeostasis of the organism. Here, we review the origin, properties and applications of myogenic stem cells, and the vital signal proteins involved in myogenic stem cells differentiation will be referred to as well.
Export Options
About this article
Cite this article as:
Huang Zhiqing, Wang Xiaoyan and Chen Daiwen*, Signal Proteins Involved in Myogenic Stem Cells Differentiation, Current Protein & Peptide Science 2017; 18 (6) . https://dx.doi.org/10.2174/1389203717666160623090321
DOI https://dx.doi.org/10.2174/1389203717666160623090321 |
Print ISSN 1389-2037 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5550 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Epidemiology of Sepsis
Current Pharmaceutical Design Current and Emerging Therapies in Neuroendocrine Tumors: Impact of Genetic Targets on Clinical Outcomes
Clinical Cancer Drugs C. elegans as Model for Drug Discovery
Current Topics in Medicinal Chemistry Targeting ErbB3: the New RTK(id) on the Prostate Cancer Block
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Biomarkers in Molecularly Targeted Therapy for Cancer
Recent Patents on Biomarkers Role of Renin Angiotensin System Inhibitors in Cardiovascular and Renal Protection: A Lesson from Clinical Trials
Current Pharmaceutical Design The Design of Drug Candidate Molecules as Selective Inhibitors of Therapeutically Relevant Protein Kinases
Current Medicinal Chemistry Proline-Rich Peptides: Multifunctional Bioactive Molecules as New Potential Therapeutic Drugs
Current Protein & Peptide Science P53 Family: At the Crossroads in Cancer Therapy
Current Medicinal Chemistry HtrA Protease Family as Therapeutic Targets
Current Pharmaceutical Design Anesthesia for Bronchoscopy
Current Pharmaceutical Design Cardiovascular Effects of EGFR (Epidermal Growth Factor Receptor) Monoclonal Antibodies
Cardiovascular & Hematological Agents in Medicinal Chemistry FOXO and FOXM1 in Cancer: The FOXO-FOXM1 Axis Shapes the Outcome of Cancer Chemotherapy
Current Drug Targets New Insight into P-Glycoprotein as a Drug Target
Anti-Cancer Agents in Medicinal Chemistry Pharmacogenetics of Target Genes Across Doxorubicin Disposition Pathway: A Review
Current Drug Metabolism The 9p21 Locus and its Potential Role in Atherosclerosis Susceptibility; Molecular Mechanisms and Clinical Implications
Current Pharmaceutical Design Severe Neutropenia in a Renal Transplant Patient Suggesting an Interaction Between Mycophenolate and Fenofibrate
Current Drug Safety The VHL Tumor Suppressor: Master Regulator of HIF
Current Pharmaceutical Design Roles of IL-6-gp130 Signaling in Vascular Inflammation
Current Cardiology Reviews Antiproliferative Effects of Nerium oleander Leaves and Their Cardiac Glycosides Odoroside A and Oleandrin on MCF-7 Cancer Cells
Current Traditional Medicine